ID   GUC2C_HUMAN             Reviewed;        1073 AA.
AC   P25092; B2RMY6;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=Heat-stable enterotoxin receptor;
DE            Short=STA receptor;
DE            Short=hSTAR;
DE            EC=4.6.1.2;
DE   AltName: Full=Guanylyl cyclase C;
DE            Short=GC-C;
DE   AltName: Full=Intestinal guanylate cyclase;
DE   Flags: Precursor;
GN   Name=GUCY2C; Synonyms=GUC2C, STAR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-281.
RX   PubMed=1718270; DOI=10.1016/0006-291X(91)91736-V;
RA   Singh S., Singh G., Heim J.-M., Gerzer R.;
RT   "Isolation and expression of a guanylate cyclase-coupled heat stable
RT   enterotoxin receptor cDNA from a human colonic cell line.";
RL   Biochem. Biophys. Res. Commun. 179:1455-1463(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-281.
RX   PubMed=1680854;
RA   de Sauvage F.J., Camerato T.R., Goeddel D.V.;
RT   "Primary structure and functional expression of the human receptor for
RT   Escherichia coli heat-stable enterotoxin.";
RL   J. Biol. Chem. 266:17912-17918(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-281.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-281.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-72.
RC   TISSUE=Placenta;
RX   PubMed=8605253; DOI=10.1016/0167-4781(95)00190-5;
RA   Mann E.A., Jump M.L., Giannella R.A.;
RT   "Cell line-specific transcriptional activation of the promoter of the
RT   human guanylyl cyclase C/heat-stable enterotoxin receptor gene.";
RL   Biochim. Biophys. Acta 1305:7-10(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 24-1073, AND VARIANT LEU-281.
RC   TISSUE=Colon carcinoma;
RX   PubMed=8381596;
RA   Mann E.A., Cohen M.B., Giannella R.A.;
RT   "Comparison of receptors for Escherichia coli heat-stable enterotoxin:
RT   novel receptor present in IEC-6 cells.";
RL   Am. J. Physiol. 264:G172-G178(1993).
RN   [8]
RP   SUBUNIT.
RX   PubMed=11123935; DOI=10.1021/bi0013849;
RA   Vijayachandra K., Guruprasad M., Bhandari R., Manjunath U.H.,
RA   Somesh B.P., Srinivasan N., Suguna K., Visweswariah S.S.;
RT   "Biochemical characterization of the intracellular domain of the human
RT   guanylyl cyclase C receptor provides evidence for a catalytically
RT   active homotrimer.";
RL   Biochemistry 39:16075-16083(2000).
RN   [9]
RP   INTERACTION WITH PDZK2.
RX   PubMed=11950846; DOI=10.1074/jbc.M202434200;
RA   Scott R.O., Thelin W.R., Milgram S.L.;
RT   "A novel PDZ protein regulates the activity of guanylyl cyclase C, the
RT   heat-stable enterotoxin receptor.";
RL   J. Biol. Chem. 277:22934-22941(2002).
RN   [10]
RP   GLYCOSYLATION AT ASN-32; ASN-75; ASN-79; ASN-195; ASN-284; ASN-307;
RP   ASN-345 AND ASN-402, LACK OF GLYCOSYLATION AT ASN-357, INTERACTION
RP   WITH VIP36, AND SUBCELLULAR LOCATION.
RX   PubMed=23269669; DOI=10.1074/jbc.M112.413906;
RA   Arshad N., Ballal S., Visweswariah S.S.;
RT   "Site-specific N-linked glycosylation of receptor guanylyl cyclase C
RT   regulates ligand binding, ligand-mediated activation and interaction
RT   with vesicular integral membrane protein 36, VIP36.";
RL   J. Biol. Chem. 288:3907-3917(2013).
RN   [11]
RP   VARIANT MECIL GLY-387, AND CHARACTERIZATION OF VARIANT MECIL GLY-387.
RX   PubMed=22521417; DOI=10.1016/j.ajhg.2012.03.022;
RA   Romi H., Cohen I., Landau D., Alkrinawi S., Yerushalmi B.,
RA   Hershkovitz R., Newman-Heiman N., Cutting G.R., Ofir R., Sivan S.,
RA   Birk O.S.;
RT   "Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-
RT   activating guanylate cyclase 2C.";
RL   Am. J. Hum. Genet. 90:893-899(2012).
RN   [12]
RP   VARIANT DIAR6 ILE-840, AND CHARACTERIZATION OF VARIANT DIAR6 ILE-840.
RX   PubMed=22436048; DOI=10.1056/NEJMoa1110132;
RA   Fiskerstrand T., Arshad N., Haukanes B.I., Tronstad R.R., Pham K.D.,
RA   Johansson S., Havik B., Tonder S.L., Levy S.E., Brackman D., Boman H.,
RA   Biswas K.H., Apold J., Hovdenak N., Visweswariah S.S., Knappskog P.M.;
RT   "Familial diarrhea syndrome caused by an activating GUCY2C mutation.";
RL   N. Engl. J. Med. 366:1586-1595(2012).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-30; ARG-61; GLN-114; LEU-464;
RP   LYS-610; VAL-859; ARG-1045 AND CYS-1072.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for the E.coli heat-stable enterotoxin (E.coli
CC       enterotoxin markedly stimulates the accumulation of cGMP in
CC       mammalian cells expressing GC-C). Also activated by the endogenous
CC       peptides guanylin and uroguanylin.
CC   -!- CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.
CC   -!- SUBUNIT: Homotrimer. Interacts via its C-terminal region with
CC       PDZK2. Interacts with the lectin chaperone VIP36.
CC       {ECO:0000269|PubMed:11123935, ECO:0000269|PubMed:11950846,
CC       ECO:0000269|PubMed:23269669}.
CC   -!- INTERACTION:
CC       Q86UT5-2:PDZD3; NbExp=4; IntAct=EBI-2816795, EBI-8299496;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23269669};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:23269669}.
CC       Endoplasmic reticulum membrane {ECO:0000269|PubMed:23269669};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:23269669}.
CC       Note=The 145 kDa plasma membrane form of GC-C contains sialic acid
CC       and galactose residues, while a differencially glycosylated 130
CC       Kda form is a high mannose form that is resident in the
CC       endoplasmic reticulum and may serve as the precursor for the cell
CC       surface form.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- PTM: Glycosylation at Asn-75 and/or Asn-79 is required for
CC       interaction with VIP36 while glycosylation at Asn-345 and Asn-402
CC       modulates ligand-mediated GC-C activation.
CC       {ECO:0000269|PubMed:23269669}.
CC   -!- DISEASE: Diarrhea 6 (DIAR6) [MIM:614616]: A relatively mild,
CC       early-onset chronic diarrhea that may be associated with increased
CC       susceptibility to inflammatory bowel disease, small bowel
CC       obstruction, and esophagitis. {ECO:0000269|PubMed:22436048}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Meconium ileus (MECIL) [MIM:614665]: A condition
CC       characterized by a intestinal obstruction due to inspissated
CC       meconium in the distal ileum and cecum, which develops in utero
CC       and presents shortly after birth as a failure to pass meconium.
CC       Meconium ileus is a known clinical manifestation of cystic
CC       fibrosis. {ECO:0000269|PubMed:22521417}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GUCY2CID43303ch12p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S57551; AAB19934.2; -; mRNA.
DR   EMBL; M73489; AAA36655.1; -; mRNA.
DR   EMBL; AC007545; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471094; EAW96324.1; -; Genomic_DNA.
DR   EMBL; BC136544; AAI36545.1; -; mRNA.
DR   EMBL; BC136545; AAI36546.1; -; mRNA.
DR   EMBL; U20230; AAC50381.1; -; Genomic_DNA.
DR   CCDS; CCDS8664.1; -.
DR   PIR; A40940; OYHUHX.
DR   RefSeq; NP_004954.2; NM_004963.3.
DR   UniGene; Hs.524278; -.
DR   ProteinModelPortal; P25092; -.
DR   BioGrid; 109239; 1.
DR   IntAct; P25092; 3.
DR   MINT; MINT-261763; -.
DR   STRING; 9606.ENSP00000261170; -.
DR   ChEMBL; CHEMBL1795197; -.
DR   DrugBank; DB08890; Linaclotide.
DR   GuidetoPHARMACOLOGY; 1750; -.
DR   TCDB; 8.A.85.1.1; the guanylate cyclase (gc) family.
DR   iPTMnet; P25092; -.
DR   PhosphoSitePlus; P25092; -.
DR   BioMuta; GUCY2C; -.
DR   DMDM; 311033390; -.
DR   MaxQB; P25092; -.
DR   PaxDb; P25092; -.
DR   PeptideAtlas; P25092; -.
DR   PRIDE; P25092; -.
DR   DNASU; 2984; -.
DR   Ensembl; ENST00000261170; ENSP00000261170; ENSG00000070019.
DR   GeneID; 2984; -.
DR   KEGG; hsa:2984; -.
DR   UCSC; uc001rcd.4; human.
DR   CTD; 2984; -.
DR   DisGeNET; 2984; -.
DR   GeneCards; GUCY2C; -.
DR   H-InvDB; HIX0036867; -.
DR   HGNC; HGNC:4688; GUCY2C.
DR   HPA; HPA037655; -.
DR   HPA; HPA073759; -.
DR   MalaCards; GUCY2C; -.
DR   MIM; 601330; gene.
DR   MIM; 614616; phenotype.
DR   MIM; 614665; phenotype.
DR   neXtProt; NX_P25092; -.
DR   OpenTargets; ENSG00000070019; -.
DR   Orphanet; 314373; Chronic diarrhea due to guanylate cyclase 2C overactivity.
DR   Orphanet; 314376; Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency.
DR   PharmGKB; PA29069; -.
DR   eggNOG; KOG1023; Eukaryota.
DR   eggNOG; COG2114; LUCA.
DR   GeneTree; ENSGT00760000118959; -.
DR   HOGENOM; HOG000112833; -.
DR   HOVERGEN; HBG106967; -.
DR   InParanoid; P25092; -.
DR   KO; K12320; -.
DR   OMA; APDYMKN; -.
DR   OrthoDB; EOG091G01F8; -.
DR   PhylomeDB; P25092; -.
DR   BRENDA; 4.6.1.2; 2681.
DR   Reactome; R-HSA-8935690; Miscellaneous digestion events.
DR   Reactome; R-HSA-8942233; Intestinal infectious diseases.
DR   SIGNOR; P25092; -.
DR   GeneWiki; Guanylate_cyclase_2C; -.
DR   GenomeRNAi; 2984; -.
DR   PRO; PR:P25092; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000070019; -.
DR   CleanEx; HS_GUCY2C; -.
DR   CleanEx; HS_STAR; -.
DR   Genevisible; P25092; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008074; C:guanylate cyclase complex, soluble; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0015643; F:toxic substance binding; IEA:Ensembl.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0007586; P:digestion; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   Gene3D; 3.30.70.1230; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; cGMP biosynthesis; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; GTP-binding; Lyase; Membrane;
KW   Nucleotide-binding; Polymorphism; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   1073       Heat-stable enterotoxin receptor.
FT                                /FTId=PRO_0000012376.
FT   TOPO_DOM     24    430       Extracellular. {ECO:0000255}.
FT   TRANSMEM    431    454       Helical. {ECO:0000255}.
FT   TOPO_DOM    455   1073       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      489    749       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      824    954       Guanylate cyclase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   SITE        357    357       Not glycosylated.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD     32     32       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD    284    284       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD    307    307       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD    345    345       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   CARBOHYD    402    402       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23269669}.
FT   VARIANT      30     30       C -> R (in dbSNP:rs56142849).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042221.
FT   VARIANT      61     61       G -> R (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042222.
FT   VARIANT     114    114       R -> Q (in dbSNP:rs56275235).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042223.
FT   VARIANT     281    281       F -> L (in dbSNP:rs1420635).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1680854,
FT                                ECO:0000269|PubMed:1718270,
FT                                ECO:0000269|PubMed:8381596,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_049253.
FT   VARIANT     387    387       D -> G (in MECIL; activation of guanylate
FT                                cyclase activity is 60% lower than in
FT                                wild-type; dbSNP:rs587776905).
FT                                {ECO:0000269|PubMed:22521417}.
FT                                /FTId=VAR_068174.
FT   VARIANT     464    464       R -> L (in dbSNP:rs55684775).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042224.
FT   VARIANT     610    610       E -> K (in dbSNP:rs55897626).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042225.
FT   VARIANT     840    840       S -> I (in DIAR6; activating mutation;
FT                                exposure of the mutant receptor to its
FT                                ligands results in markedly increased
FT                                production of cyclic guanosine
FT                                monophosphate; dbSNP:rs587776871).
FT                                {ECO:0000269|PubMed:22436048}.
FT                                /FTId=VAR_067724.
FT   VARIANT     859    859       I -> V (in dbSNP:rs34890806).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042226.
FT   VARIANT    1045   1045       Q -> R (in dbSNP:rs35617837).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042227.
FT   VARIANT    1072   1072       Y -> C (in dbSNP:rs35179392).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042228.
FT   CONFLICT    322    322       A -> R (in Ref. 1; AAB19934).
FT                                {ECO:0000305}.
FT   CONFLICT    331    331       L -> V (in Ref. 1; AAB19934).
FT                                {ECO:0000305}.
FT   CONFLICT    509    509       D -> V (in Ref. 1; AAB19934).
FT                                {ECO:0000305}.
FT   CONFLICT    543    543       N -> T (in Ref. 1; AAB19934).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1073 AA;  123403 MW;  486A4DE6F9097E22 CRC64;
     MKTLLLDLAL WSLLFQPGWL SFSSQVSQNC HNGSYEISVL MMGNSAFAEP LKNLEDAVNE
     GLEIVRGRLQ NAGLNVTVNA TFMYSDGLIH NSGDCRSSTC EGLDLLRKIS NAQRMGCVLI
     GPSCTYSTFQ MYLDTELSYP MISAGSFGLS CDYKETLTRL MSPARKLMYF LVNFWKTNDL
     PFKTYSWSTS YVYKNGTETE DCFWYLNALE ASVSYFSHEL GFKVVLRQDK EFQDILMDHN
     RKSNVIIMCG GPEFLYKLKG DRAVAEDIVI ILVDLFNDQY FEDNVTAPDY MKNVLVLTLS
     PGNSLLNSSF SRNLSPTKRD FALAYLNGIL LFGHMLKIFL ENGENITTPK FAHAFRNLTF
     EGYDGPVTLD DWGDVDSTMV LLYTSVDTKK YKVLLTYDTH VNKTYPVDMS PTFTWKNSKL
     PNDITGRGPQ ILMIAVFTLT GAVVLLLLVA LLMLRKYRKD YELRQKKWSH IPPENIFPLE
     TNETNHVSLK IDDDKRRDTI QRLRQCKYDK KRVILKDLKH NDGNFTEKQK IELNKLLQID
     YYNLTKFYGT VKLDTMIFGV IEYCERGSLR EVLNDTISYP DGTFMDWEFK ISVLYDIAKG
     MSYLHSSKTE VHGRLKSTNC VVDSRMVVKI TDFGCNSILP PKKDLWTAPE HLRQANISQK
     GDVYSYGIIA QEIILRKETF YTLSCRDRNE KIFRVENSNG MKPFRPDLFL ETAEEKELEV
     YLLVKNCWEE DPEKRPDFKK IETTLAKIFG LFHDQKNESY MDTLIRRLQL YSRNLEHLVE
     ERTQLYKAER DRADRLNFML LPRLVVKSLK EKGFVEPELY EEVTIYFSDI VGFTTICKYS
     TPMEVVDMLN DIYKSFDHIV DHHDVYKVET IGDAYMVASG LPKRNGNRHA IDIAKMALEI
     LSFMGTFELE HLPGLPIWIR IGVHSGPCAA GVVGIKMPRY CLFGDTVNTA SRMESTGLPL
     RIHVSGSTIA ILKRTECQFL YEVRGETYLK GRGNETTYWL TGMKDQKFNL PTPPTVENQQ
     RLQAEFSDMI ANSLQKRQAA GIRSQKPRRV ASYKKGTLEY LQLNTTDKES TYF
//
